As we've heard, cannabis in Canada went fully legal nationwide on Oct. 17.
But the story - and the profits - are just getting started.
After all, there's potentially $22.6 billion a year up for grabs.
Let me take you "north of the border" to show you what the big day was really like for politicians, police, cannabis connoisseurs, and investors.
As we've heard, cannabis in Canada went fully legal nationwide on Oct. 17.
But the story - and the profits - are just getting started.
After all, there's potentially $22.6 billion a year up for grabs.
Let me take you "north of the border" to show you what the big day was really like for politicians, police, cannabis connoisseurs, and investors.
Here we are.
It's taken years of trials and experiments, but this week, the U.S. Food and Drug Administration (FDA) made history by approving the first cannabis plant-derived drug pharmaceutical.
And that makes the drug's developer and owner, as well as our long-time Roadmap to Marijuana Millions cannabis biotech play - the United Kingdom's GW Pharmaceuticals Plc. - a pioneer in marijuana-based medical treatments.
What a week to be early investors in weed...
Public sentiment is shifting toward recreational marijuana use in the U.S., and that's a good sign for pot stocks - and investors who get in ahead of the boom...
But, it's also benefiting Peyton Manning...?
Here’s the story (plus how to make money)...
Four new pot stocks to watch have just starting trading, all hailing from our neighbor to the North.
That's because a recent policy change in Canada has legitimized the cannabis business - a market that's expected to generate $3.4 billion a year in taxable sales over the next decade, according to government estimates.
